Odevixibat: A Review of a Bioactive Compound for the Treatment of Pruritus Approved by the FDA.

Porwal, Mayur; Kumar, Arvind; Rastogi, Vaibhav; Maheshwari, Kamal Kishore; Verma, Anurag

Porwal, Mayur; Kumar, Arvind; Rastogi, Vaibhav; Maheshwari, Kamal Kishore; Verma, Anurag.

Afiliación

Porwal M; Department of Pharmacology, Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad, 244001, Uttar Pradesh, India.
Kumar A; Drug Design Laboratory, School of Pharmaceutical Sciences, IFTM University, Moradabad, 244001, Uttar Pradesh, India.
Rastogi V; Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad, 244001, Uttar Pradesh, India.
Maheshwari KK; Department of Pharmacy, M.J.P.Rohilkhand University, Bareilly, 243001, Uttar Pradesh, India.
Verma A; Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad, 244001, Uttar Pradesh, India.

Curr Drug Res Rev ; 2023 Mar 08.

Article en En | MEDLINE | ID: mdl-36892028

Palabras clave

Alagille syndrome; FDA; Odevixibat; bile acid cotransporter.; biliary atresia; intrahepatic cholestasis; pruritis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Curr Drug Res Rev Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google